Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.270
+0.090 (4.13%)
At close: Oct 8, 2025, 4:00 PM EDT
2.290
+0.020 (0.88%)
After-hours: Oct 8, 2025, 7:55 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Autologous Tumor Infiltrating Lymphocyte Cell Therapies
164.07M
Log In
Autologous Tumor Infiltrating Lymphocyte Cell Therapies Growth
13698.99%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
161.04M
Log In
United States Growth
13444.41%
Log In
Rest of World
3.03M
Log In